Compare GCTK & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GCTK | NUWE |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | United States |
| Employees | N/A | 38 |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4M | 1.7M |
| IPO Year | 2011 | N/A |
| Metric | GCTK | NUWE |
|---|---|---|
| Price | $0.81 | $1.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 31.1K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 31.22 | N/A |
| Revenue | ★ $589,462.00 | N/A |
| Revenue This Year | N/A | $11.14 |
| Revenue Next Year | N/A | $18.51 |
| P/E Ratio | $0.03 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.09 | $0.19 |
| 52 Week High | $15.90 | $25.95 |
| Indicator | GCTK | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 44.93 | 42.11 |
| Support Level | $0.64 | $0.96 |
| Resistance Level | $1.02 | $1.19 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 23.08 | 11.60 |
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.